Potential role of hypovitaminosis D and vitamin D supplementation during COVID-19 pandemic
Author(s) -
Monica Verdoia,
Giuseppe De Luca
Publication year - 2020
Publication title -
qjm
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 118
eISSN - 1460-2725
pISSN - 1460-2393
DOI - 10.1093/qjmed/hcaa234
Subject(s) - vitamin d and neurology , hypovitaminosis , pandemic , covid-19 , vitamin d deficiency , medicine , virology , disease , outbreak , infectious disease (medical specialty)
Summary Vitamin D deficiency is a pandemic disorder affecting over 1 billion of subjects worldwide and displaying a broad spectrum of implications on cardiovascular and inflammatory disorders. Since the initial reports of the association between hypovitaminosis D and COVID-19, Vitamin D has been pointed as a potentially interesting treatment for SARS-CoV-2 infection. We provide an overview on the current status of vitamin D deficiency, the mechanisms of action of vitamin D and the current literature on the topic, with a special focus on the potential implications for COVID-19 pandemic.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom